← back to search

Mark P. Molloy

The University of Sydney · AU
Area of research
Spectroscopy · Cancer Research
Research interest
Research interests include Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications, Cancer, Hypoxia, and Metabolism, and Gastrointestinal Tumor Research and Treatment.
h-index
53
citations
12,088
works
405
NIH funding
primary concept
email

Recent publications

Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions
Cancers 2025cited by 8position: middledoi
Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility
Cancer Immunology Immunotherapy 2024cited by 21position: lastdoi
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria
Nature Communications 2023cited by 60position: middledoi
Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing
Cancers 2023cited by 33position: lastdoi
Quantification of short-chain fatty acids in human stool samples by LC-MS/MS following derivatization with aniline analogues
Journal of Chromatography B 2023cited by 20position: lastdoi
Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
Alzheimer s & Dementia 2022cited by 282position: middledoi
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition
Alzheimer s & Dementia 2022cited by 83position: middledoi
SERS characterization of colorectal cancer cell surface markers upon anti‐EGFR treatment
Exploration 2022cited by 44position: middledoi
Recurrence patterns predict survival after resection of colorectal liver metastases
ANZ Journal of Surgery 2022cited by 44position: middledoi
Overlapping genes in natural and engineered genomes
Nature Reviews Genetics 2021cited by 150position: middledoi
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Frontiers in Oncology 2021cited by 60position: middledoi
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Cancers 2021cited by 59position: middledoi
Changes in dietary fiber intake in mice reveal associations between colonic mucin <i>O</i>-glycosylation and specific gut bacteria
Gut Microbes 2020cited by 66position: middledoi
PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression
Biochimica et Biophysica Acta (BBA) - General Subjects 2020cited by 32position: middledoi
Protein Paucimannosylation Is an Enriched <i>N</i> ‐Glycosylation Signature of Human Cancers
PROTEOMICS 2019cited by 89position: middledoi
Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry
Nature Communications 2017cited by 613position: middledoi
Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes
Scientific Reports 2017cited by 141position: middledoi
Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy
Cellular and Molecular Life Sciences 2017cited by 51position: middledoi
Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype
Human Molecular Genetics 2017cited by 50position: middledoi
Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF <sup>(cyclin F)</sup> complex
Open Biology 2017cited by 30position: middledoi
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
Nature Communications 2016cited by 207position: middledoi
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
British Journal of Cancer 2015cited by 53position: middledoi
Comprehensive glycomics comparison between colon cancer cell cultures and tumours: Implications for biomarker studies
Journal of Proteomics 2014cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stephen Clarke · Carnegie Mellon University5 papers (2014–2024)Nicholas J. Cole · King's College London3 papers (2017–2017)Nick Pavlakis · University of Sydney3 papers (2015–2021)Albert Lee · Cancer Research Institute3 papers (2017–2017)Serene S. L. Gwee · Macquarie University3 papers (2017–2017)Roger S. Chung · New South Wales Department of Health3 papers (2017–2017)Emily K. Don · Macquarie University3 papers (2017–2017)Marco Morsch · Macquarie University3 papers (2017–2017)Stephanie L. Rayner · Macquarie University3 papers (2017–2017)Kelly L. Williams · University of Edinburgh3 papers (2017–2017)Ian P. Blair · Macquarie University3 papers (2017–2017)Michael Back · The University of Sydney3 papers (2021–2025)Thomas Eade · The University of Sydney3 papers (2021–2025)Byeongsang Oh · The University of Sydney3 papers (2021–2025)Frances Boyle · University of Sydney2 papers (2021–2021)Hamideh Shahheydari · Macquarie University2 papers (2017–2017)Towia A. Libermann · Beth Israel Deaconess Medical Center2 papers (2021–2021)Susan Carroll · University College Cork2 papers (2021–2021)George Hruby · The University of Sydney2 papers (2021–2021)Vinod Sundaramoorthy · Macquarie University2 papers (2017–2017)